Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Heparin-like anticoagulant associated with multiple myeloma and neutralized with protamine sulfate.

Torjemane L, Guermazi S, Ladeb S, Ben Romdhane N, Lakhal A, Abdelkefi A, Ben Othman T, Ben Abdelhadhim A.

Blood Coagul Fibrinolysis. 2007 Apr;18(3):279-81.

PMID:
17413766
2.

Heparin-like anticoagulant associated with plasma cell myeloma.

Chapman GS, George CB, Danley DL.

Am J Clin Pathol. 1985 Jun;83(6):764-6.

PMID:
3923825
3.

Neutralization of enoxaparine-induced bleeding by protamine sulfate.

Van Ryn-McKenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR.

Thromb Haemost. 1990 Apr 12;63(2):271-4.

PMID:
2163553
4.

Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma.

Tefferi A, Owen BA, Nichols WL, Witzig TE, Owen WG.

Blood. 1989 Jul;74(1):252-4.

5.

Anticoagulant effects of protamine sulfate in a canine model.

Kresowik TF, Wakefield TW, Fessler RD 2nd, Stanley JC.

J Surg Res. 1988 Jul;45(1):8-14.

6.

A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia.

Bussel JB, Steinherz PG, Miller DR, Hilgartner MW.

Am J Hematol. 1984 Jan;16(1):83-90.

PMID:
6582779
7.

Protamine sulfate neutralization of the anticoagulant activity of Aprosulate, a synthetic sulfated lactobionic acid amide.

Kijowski R, Hoppensteadt D, Jeske W, Fareed J.

Thromb Res. 1994 Mar 1;73(5):349-59.

PMID:
8016819
8.

Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder.

Palmer RN, Rick ME, Rick PD, Zeller JA, Gralnick HR.

N Engl J Med. 1984 Jun 28;310(26):1696-9.

PMID:
6233489
9.

Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation.

Ni Ainle F, Preston RJ, Jenkins PV, Nel HJ, Johnson JA, Smith OP, White B, Fallon PG, O'Donnell JS.

Blood. 2009 Aug 20;114(8):1658-65. doi: 10.1182/blood-2009-05-222109. Epub 2009 Jun 16.

10.

Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice.

Bernat A, Hoffmann P, Herbert JM.

Thromb Haemost. 1996 Nov;76(5):715-9.

PMID:
8950779
11.

Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?

Teoh KH, Young E, Blackall MH, Roberts RS, Hirsh J.

J Thorac Cardiovasc Surg. 2004 Aug;128(2):211-9.

12.

Heparin-like anticoagulant associated with systemic candidiasis.

Horne MK 3rd, Chao ES, Wilson OJ.

Am J Hematol. 1990 Sep;35(1):37-42.

PMID:
2389767
13.

A glycosaminoglycan inhibitor of thrombin: a new mechanism for abnormal hemostatic assays in cancer.

Liebman HA, Comenzo R, Allen ST, Dilorio JM.

Am J Hematol. 1991 Sep;38(1):24-9.

PMID:
1897511
14.

Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder.

Colwell NS, Tollefsen DM, Blinder MA.

Br J Haematol. 1997 Apr;97(1):219-26.

PMID:
9136969
16.
17.

Acquired dysfibrinogenemia secondary to multiple myeloma.

Kotlín R, Sobotková A, Riedel T, Salaj P, Suttnar J, Reicheltová Z, Májek P, Khaznadar T, Dyr JE.

Acta Haematol. 2008;120(2):75-81. doi: 10.1159/000160182. Epub 2008 Oct 8.

PMID:
18841003
18.

Incomplete reversal of enoxaparin-induced bleeding by protamine sulfate.

Bang CJ, Berstad A, Talstad I.

Haemostasis. 1991;21(3):155-60.

PMID:
1663475
19.

Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma.

Wages DS, Staprans I, Hambleton J, Bass NM, Corash L.

Am J Hematol. 1998 Aug;58(4):285-92.

20.

Neutralization of DHG, a new depolymerized holothurian glycosaminoglycan, by protamine sulfate and platelet factor 4.

Sasaki E, Minamiguchi K, Kitazato KT, Nagase H, Kitazato K.

Haemostasis. 1997 Jul-Aug;27(4):174-83.

PMID:
9483172

Supplemental Content

Support Center